ClinicalTrials.gg
CompletedNCT04418778Updated Nov 12, 2026

The BEAR Therapeutic Program for Women

An observational study in Trauma, Psychological, Depression, Anxiety and PTSD, sponsored by Stanford University. Completed at 1 site in United States. Open to female participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Stanford University · Observational

How we know

Updated Nov 12, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
36
Ages
18 Years to 70 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 51 studies in Psychological Trauma with a site in United States — 12 open to participants now, 14 under way, none of them phase 3. Psychological Trauma · United States.

Started
2023
with 2 others
Observational
9 of 51
2 open now
Registered
23rd of 51
by date

Among the 51 studies in Psychological Trauma with a site in United States, this one is one of 3 that started in 2023, is one of 9 observational ones, and was the 23rd registered.

Psychological Trauma

141 studies on the registry are indexed under Psychological Trauma; 42 are open to participants now.

Browse Psychological Trauma studies →

Open to participants now

12 of the 51 studies in Psychological Trauma with a site in United States are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 27 Psychological Trauma studies recruiting now, 12 (44%) set no upper age limit and 14 (52%) stop at 75 or younger; 8 take children under 18; 10 take healthy volunteers.

This study: 18 Years to 70 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 51 studies in Psychological Trauma with a site in United States, or all of them as a file.
02

Study summary

The current study aims to test a novel therapeutic intervention for women who have a history of interpersonal trauma. The Building Empowerment and Resilience (BEAR) Therapeutic group incorporates psychological skills, psychoeducation, and physical empowerment training, all within a therapeutic process. It will be implemented iwith women who have experienced interpersonal trauma (physical, sexual, or emotional abuse/neglect). The investigators aim to understand how this program effects one's self-efficacy and whether the program can reduce rates mental health problems (such as depression and anxiety) and reduce the rates of revictimization. Women who participate in the BEAR group must be able to attend in-person sessions. The control group can be remote.

03

Conditions studied

  • Trauma, Psychological
  • Depression, Anxiety
  • PTSD

Keywords

  • empowerment
  • therapeutic intervention
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women who have experienced interpersonal violence broadly defined

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Women ages 18-70
  2. History of physical, sexual, and/or emotional abuse/neglect/violence, with subsequent interpersonal or psychological distress (e.g., depression or anxiety) related to this history.

Exclusion criteria

Exclusion Criteria:

  1. Active, significant substance abuse
  2. Significant medical conditions that would preclude safe participation in the study
  3. High levels of depression with significant suicide risk
  4. Psychiatric instability
  5. History of assaultive behavior or is judged to be at potential risk to assault others.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
36 participants (actual)
Patient registry
No

Groups and cohorts

  • BEAR intervention group

    BEAR Therapeutic group for women who have experienced interpersonal trauma

    Behavioral: BEAR

  • Control Condition

    Treatment as usual group, women participating in individual or group therapy but not taking the BEAR group

Interventions

  • BehavioralBEAR

    Building Empowerment and Resilience Therapy group

06

What researchers measure

Primary outcomes

  1. Change in Coping Self-Efficacy Scale (CSES)

    The CSES is designed to measure an individual's perception of her competence to carry out coping strategies effectively when faced with a challenge or threat.

    Time frame: baseline to post-group (3 months)

  2. Trauma Symptom Inventory-II (TSI-2).

    The TSI-2 is a self-report measure of trauma-related symptoms and behaviors.

    Time frame: baseline to post-group (3 months)

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2023 to primary completion in Apr 2025, 25 months.

Of 20 observational studies under Psychological Trauma, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 25 and three quarters within 53. This study's 25 months is below that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: primary completion Jul 2025 → Apr 2025 and completion Jul 2026 → Apr 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 29, 2020
First posted
Jun 5, 2020
StartActual
Mar 1, 2023
Primary completionActual
Apr 1, 2025was Jul 2025
CompletionActual
Apr 1, 2026was Jul 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 12, 2026
Primary completion
Jul 2025→Apr 1, 2025 (actual)
Nov 12, 2026
Study completion
Jul 2026→Apr 1, 2026 (actual)
Nov 12, 2026
Enrollment
120 (estimated)→36 (actual)
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Active, not recruiting→Completed
    Primary completion Jul 2025→Apr 1, 2025 (now actual)
    Study completion Jul 2026→Apr 1, 2026 (now actual)
    Enrollment 120 (estimated)→36 (actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT04418778
Responsible party
Jennifer Keller (Clinical Professor, Stanford University) — Principal investigator
First posted
Jun 5, 2020
Start date
Mar 1, 2023
Primary completion
Apr 1, 2025
Completion
Apr 1, 2026
Last update
Nov 12, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion